ClinicalTrials.Veeva

Menu

PEEK Versus Silicon Interspinous Spacer for Reduction of Supradjacent Segment Degeneration (WallisvsDiam)

U

University Hospital of Patras

Status

Completed

Conditions

Adjacent Segment Degeneration

Treatments

Procedure: PEEK interspinous spacer

Study type

Interventional

Funder types

Other

Identifiers

NCT03477955
WALLIS2018

Details and patient eligibility

About

A retrospective study that aims to report Adjacent Segment Degeneration (ASD) incidence and spinopelvic balance in short lumbosacral instrumentation for degenerative lumbar spinal stenosis. Although ASD is a common complication following lumbar fusion, the effect of an Interspinous Spacer (IS) in the supradjacent segment in short lumbosacral instrumented fusion and its interaction with spinopelvic balance has not been studied adequately.

Full description

Methods From 55 consecutive age-, diagnosis- and gender- matched patients aged 60±11 years, 17 (Group R) received PEEK IS; 18 (Group S) received Silicon IS and compared with 20 controls (Group C) without receiving any IS. The functional outcome was evaluated with VAS and ODI. Spinopelvic balance was evaluated using SVA, T12-S1 LL, SS, PT, PI and supradjacent segment disc heights. All spines were preoperatively balanced.

Enrollment

55 patients

Sex

All

Ages

49 to 71 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Preoperative MRI with degeneration grades<III at the 1st supradjacent lumbar segment.

Exclusion criteria

  • Body mass index≥40kg/m*m
  • Severe osteoporosis
  • Lumbar fracture
  • Preoperative SVA>4cm
  • Spondylolisthesis grades>II or spondylolytic lesion and acquired spinous process insufficiency in the supradjacent segment cephalad to instrumentation

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

55 participants in 3 patient groups

Peek Group
Active Comparator group
Description:
Patients that received PEEK interspinous spacer
Treatment:
Procedure: PEEK interspinous spacer
Silicon Group
Active Comparator group
Description:
Patients that received Silicon interspinous spacer and did not receive PEEK interspinous spacer
Treatment:
Procedure: PEEK interspinous spacer
Control Group
Active Comparator group
Description:
Patients that did not receive PEEK interspinous spacer nor Silicon interspinous spacer
Treatment:
Procedure: PEEK interspinous spacer

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems